|
EXT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.62769814188368E-11 |
| Normal-vs-Stage2 |
4.93409757496011E-11 |
| Normal-vs-Stage3 |
8.21565038222616E-15 |
| Normal-vs-Stage4 |
6.01740879346835E-14 |
| Stage1-vs-Stage2 |
3.279400E-01 |
| Stage1-vs-Stage3 |
1.002980E-01 |
| Stage1-vs-Stage4 |
1.825750E-02 |
| Stage2-vs-Stage3 |
7.023400E-01 |
| Stage2-vs-Stage4 |
2.736200E-01 |
| Stage3-vs-Stage4 |
4.630800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88657986402541E-15 |
| Normal-vs-AfricanAmerican |
1.87728999999637E-05 |
| Normal-vs-Asian |
4.9774961929927E-11 |
| Caucasian-vs-AfricanAmerican |
4.307600E-01 |
| Caucasian-vs-Asian |
9.149800E-01 |
| AfricanAmerican-vs-Asian |
3.678200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55795384873636E-13 |
| Normal-vs-Female |
1.63191682389652E-12 |
| Male-vs-Female |
8.434000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.85519965845549E-10 |
| Normal-vs-Age(41-60Yrs) |
1.59872115546023E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62825308791525E-12 |
| Normal-vs-Age(81-100Yrs) |
1.564320E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.595000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.072430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.893000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.450400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.086200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.006200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.475900E-03 |
| Classical-VS-Follicular |
7.231400E-01 |
| Classical-VS-Other |
5.707600E-01 |
| Classical-VS-Normal |
1.6823209492145E-12 |
| Tall-VS-Follicular |
2.306500E-02 |
| Tall-VS-Other |
3.913600E-01 |
| Tall-VS-Normal |
1.11559650406434E-11 |
| Follicular-VS-Other |
7.053600E-01 |
| Follicular-VS-Normal |
2.39539998947436E-09 |
| Other-VS-Normal |
6.634600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.63624669369256E-12 |
| N0-vs-N1 |
2.208000E-01 |
|
|
